Stage IV Cutaneous Melanoma AJCC v6 and v7
|
disease |
|
Neoplastic Process
|
26
|
4
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Malignant Squamous Cell Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
193
|
12
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
664
|
22
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Central neuroblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
2419
|
231
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
CNS metastases
|
phenotype |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
102
|
14
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Solid Neoplasm
|
phenotype |
Neoplasms
|
Neoplastic Process
|
1145
|
24
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Melanoma recurrent
|
phenotype |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
12
|
1
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Adult Fibrosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
387
|
9
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Canarypox (disorder)
|
disease |
|
Disease or Syndrome
|
32
|
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Calcifying Odontogenic Cyst
|
disease |
Neoplasms; Musculoskeletal Diseases; Stomatognathic Diseases
|
Anatomical Abnormality
|
15
|
1
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Alveolar Soft Part Sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
61
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
IMMUNE SUPPRESSION
|
phenotype |
|
Disease or Syndrome
|
222
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Liposarcoma, Dedifferentiated
|
disease |
Neoplasms
|
Neoplastic Process
|
95
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neurofibromatoses
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
135
|
16
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Squamous cell carcinoma of the head and neck
|
disease |
Neoplasms
|
Neoplastic Process
|
1543
|
348
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Sarcoma
|
group |
Neoplasms
|
Neoplastic Process
|
853
|
42
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Epithelioid angiomyolipoma
|
disease |
Neoplasms
|
Neoplastic Process
|
17
|
3
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Childhood Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2420
|
231
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Basal cell carcinoma, nodular
|
disease |
Neoplasms
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Poorly differentiated sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |